CannabisNewsBreaks

TuesdayFeb 08, 2022 10:43 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Chief Strategy Officer

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Vessel founder and CEO James Chose as its new chief strategy officer. Choe brings impressive experience to his new role, with exposure to almost every major industry and a consulting business that has worked with more than 100 brands to launch more than 400 products. In particular, his time spent consulting for leading brands, cannabis producers and Fortune 500 companies has prepared Choe to serve as chief strategy office, where he will work on developing three core pillars: people, design, and community.…

Continue Reading

FridayFeb 04, 2022 11:26 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Vertically Integrating Across Multiple States

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) reported a 93% year-over-year revenue growth from $6.1 million in Q3 2020 to $11.8 million in Q3 2021. According to RWB chairman and CEO Brad Rogers, the company made excellent progress in laying additional building blocks in its core operating states of Florida, Michigan and California to become more vertically integrated “where it will be most profitable.” In Florida, the company’s operations include active cannabis cultivation sites, an operational processing facility and a dispensary. In Michigan, RWB expects to be vertically integrated upon closing a pending acquisition of an investee whose…

Continue Reading

WednesdayFeb 02, 2022 3:08 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Establishes Enviable Position in Legal Cannabis Market

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is positioned in the growing legal cannabis market, which is expected to see an estimated 16.6% growth in the coming years. “At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a ‘landmark year’ for the company, telling shareholders that in 2021 SGMD would ‘continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins,’” a recent article reads. “The strategy for 2021 appears…

Continue Reading

WednesdayFeb 02, 2022 3:00 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

Continue Reading

WednesdayFeb 02, 2022 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor ("PDE5 inhibitor") sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes…

Continue Reading

WednesdayFeb 02, 2022 12:37 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious…

Continue Reading

TuesdayFeb 01, 2022 1:49 pm

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

Continue Reading

FridayJan 28, 2022 11:12 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Closing of Embark Acquisition

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an innovative health and wellness beverages and products company, has closed on its acquisition of Embark Health Inc., solventless cannabis extraction and delivery technology provider. According to the company, the acquisition will be a significant driver of growth for BevCanna, accelerating its already strong upward trajectory. Embark owns a unique range of brands across all three cannabis 2.0 categories, meaning that BevCanna will now be able to sell differentiated and complementary adult-use and wellness products. In addition, Embark brings a British-Columbia-based, state-of-the-art production facility with $17 million  in tangible and intangible assets to…

Continue Reading

ThursdayJan 27, 2022 12:33 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is…

Continue Reading

ThursdayJan 27, 2022 11:09 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp.…

Continue Reading